M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometric...(th care indeveloping areas of the world ...)
Navigation Links
M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
Date:9/3/2007
th care in developing areas of the world by enabling health care providers to better manage medical treatment. The Four Corners Medical System provides the software necessary to manage patient record-keeping in even the most remote locations. The software is state-of-the-art and specifically engineered for use in developing countries. Gnosis is headquartered in Charlottesville, VA.
About M2SYS Technology
M2SYS Technology, http://www.m2sys.com, is a recognized industry leader in fingerprint identity-management technology, delivering a variety of customized, fully functional, turn-key fingerprint readers and software solutions for businesses and consumers. M2SYS was recently awarded the 2007 Frost and Sullivan Biometrics Technology Innovation of the Year Award.
This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com
'/>"/>
| SOURCE M2SYS Technology Copyright©2007 PR Newswire. All rights reserved |
Related biology news :
1. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
2. New study: Sexually transmitted disease treatment can be effectively administered by sex partners
3. Molecular Partners Required For Appropriate Neuronal Gene Repression
4. New partnership to clear landmines for African Elephants
5. UC San Diego partners with Venter Institute to build marine microbial genomics cyberinfrastructure
6. Gut microbes partnership helps body extract energy from food, store it as fat
7. Disease diagnosis, biodefense among UH chemical research projects
8. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
9. Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis
10. Disease diagnosis, bioengineering covered at state nano summit
11. New mitochondrial DNA gene chip may be early cancer diagnosis tool
Post Your Comments:
(Date:7/24/2008)... GAINESVILLE, Fla. If worms could talk, they migh...gle," complete with that telltale come slither loo...wn as pheromones, a complex chemical code research...ed Wednesday (July 23) in the journal Nature . ,...ell University, the California Institute of Techno...
(Date:7/24/2008)..., AMES and IOWA CITY, Iowa The University of Iow...urces to significantly enhance both institutions, ...tions have each purchased a massively parallel DNA...NA sequences at the rate of millions to billions o...th unique advantages will be available on a fee-f...
(Date:7/24/2008)... COLUMBUS, Ohio -- A single typhoon in Taiwan buri...ediment -- as all the other rains in that country ... an Ohio State University study published in a rec...-- the first ever to examine the chemistry of stre...to sea while a typhoon was happening at full force...
(Date:7/23/2008)... Converting livestock manure into a domestic renew... to meet up to three per cent of North America,s e...reduction in greenhouse gas emissions (GHGs), acco... July, in the Institute of Physics, Environmental...wer: The Energy and Emissions Benefits of Converti...
Breaking Biology News(10 mins):Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3UI and ISU establish shared DNA sequencing instrumentation 2UI and ISU establish shared DNA sequencing instrumentation 3Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Cow power could generate electricity for millions 2Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma 1766 1Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma 1766 2Celebrex Lipitor combo may halt prostate cancer 16711 1Celebrex Lipitor combo may halt prostate cancer 16711 2Celebrex Lipitor combo may halt prostate cancer 16711 3St Jude discovery offers new avenues to understanding an aggressive form of leukemia 16707 1St Jude discovery offers new avenues to understanding an aggressive form of leukemia 16707 2St Jude discovery offers new avenues to understanding an aggressive form of leukemia 16707 3PartnerWeekly and SensiClear 28TM 29 Sign Online Marketing Pact 16704 1PartnerWeekly and SensiClear 28TM 29 Sign Online Marketing Pact 16704 2...n tree may one day factor prominently in meeting t...whose research on the fast-growing poplar tree is ... journal Science. , The article, highlighting the...tree, the black cottonwood or Populus trichocarpa,...ent of trees as an ideal "feedstock" for a new gen...
...Devils Hole pupfish is a small place. The entire s... three meters wide, in a cave entrance in Death Va...mped: it also has a profound effect on the fishes,...ies can be protected from extinction. , In 1976, t...tle that reached the U.S. Supreme Court. Conservat...
...ifferences between human and chimpanzee DNA lie in...a new study. Instead, they may contain DNA sequenc...ted and read. , "The differences between chimps an...e them," said Katherine Pollard, assistant profess...t of Statistics. , Pollard and colleagues at UC...
...ake Forest University School of Medicine suggests ...s similar chemicals our bodies produce during time...ma, heart failure and lupus that involve inflammat....D., and Matthew Loza, Ph.D, found that beta-agoni..., increase the accumulation of type 2 T cells, a t...
Other Biology News:The first tree genome is published: Poplar holds promise as renewable bioenergy resource 2The first tree genome is published: Poplar holds promise as renewable bioenergy resource 3The first tree genome is published: Poplar holds promise as renewable bioenergy resource 4Comparing chimp, human DNA 2Research suggests beta agonists may alter the immune system 2(Date:7/24/2008)... Calif., July 24 /- Poniard...maceutical company focused,on oncology, today anno...ss,the Company,s second quarter results and provid...linical development plan for picoplatin, the,Compa... chairman and chief,executive officer, Ronald A. M...
(Date:7/24/2008)... 24 /- Cara Therapeutics, Inc.,announ...dditional funding,to its original $24 million Seri...und was led by new investor, Devon Park Bioventure...ations. Previous investors participating,in the ro...hi International,Corporation and Wistar Morris. In...
(Date:7/24/2008)...ly 24 /- Sagent Pharmaceuticals, Inc....y, today announced that it,has launched ceftazidim...um, beta-lactam antibiotic. Sagent will offer ceft...acy bulk package vials. According to,IMS data, 200...tes were,approximately $45.7 million., "Sagent is...
(Date:7/24/2008)...- Monsanto Company (NYSE:,M...y approvals for Roundup,Ready 2 Yield(TM) soybeans..., the company noted the European Food Safety Autho...on concluding Roundup Ready 2 Yield is,safe for im...ns are the,second generation of the popular Roundu...
Breaking Biology Technology:Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch 2[0] Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31[0] Cara Therapeutics Secures $12.3 Million in Series C Extension Financing[0] Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP[0] Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
... Madison, Wis. Developing an improved IT infrast...cal to both economic development and government ef...nual Digital Government Summit held Monday at th...lic and private entities can coordinate efforts to...l services, and business technology. In addition t...
... Madison, Wis. Governor Jim Doyle announced toda... for the state to maintain its leadership in the f...cell research. The governor said that almost $750 ...several years, and he outlined a series of investm...overy on the UW-Madison campus. , Read the lat...
... Magnified view of stem cells before they have be...urtesy of UW-Madison. Richard Moss, left, and Cli...ing the deterioration caused by acute diseases of ..., according to the ongoing research at the Univers...e Sciences and Venture Conference held Wednesday ...
... Whats the big deal, when every major corporation...ny so they can park all their mundane information ...ng the industrial age screamed against rapid autom...estruction of society. They later protested about ...he information economy. Now, listen to the roar as...
Other Biology Technology:Wisconsin introduces new state IT plan 2Wisconsin introduces new state IT plan 3Wisconsin introduces new state IT plan 4Wisconsins governor unveils $750 million investment for stem cell and health research 2UW-Madison puts heart and mind into stem cells 2UW-Madison puts heart and mind into stem cells 3Outsourcing fills gaps and drives U.S. back toward innovation 2Outsourcing fills gaps and drives U.S. back toward innovation 3Jak3 Antibody Ship: Hot Store: -20 C
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Applications: Western blotting Stability: Room temperature, indefinitely
TenderTouch™ from RNAture, Inc.
Biology Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |